Anzeige
❌
Mehr »
Freitag, 20.11.2026 - Börsentäglich über 12.000 News
Rund 40 Mio. USD Staatsaufträge bis Juni 2029 gebucht: Jetzt zählt die Marge!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PVQK | ISIN: CA03783R1073 | Ticker:
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
APPILI THERAPEUTICS INC Chart 1 Jahr
5-Tage-Chart
APPILI THERAPEUTICS INC 5-Tage-Chart

Aktuelle News zur APPILI THERAPEUTICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
13.11.Appili Therapeutics Inc. reports 1H results1
13.11.Appili Therapeutics Q2 Sales Decline1
13.11.Appili Therapeutics Inc.: Appili Therapeutics Reports Financial and Operational Results for Second Quarter of Fiscal Year 2027641Building a National Security Healthcare company focused on dual-use medical technologiesHalifax, Nova Scotia--(Newsfile Corp. - November 12, 2026) - Appili Therapeutics Inc. (NEX: APLI.H) (OTC Pink:...
► Artikel lesen
30.09.Appili Therapeutics Inc: Appili Therapeutics to be delisted from TSX Oct. 21
30.09.Appili Therapeutics Inc: Appili Therapeutics to trade on NEX Oct. 51
APPILI THERAPEUTICS Aktie jetzt für 0€ handeln
29.09.Appili Therapeutics Inc.: Appili Therapeutics Announces Transfer to NEX455Halifax, Nova Scotia--(Newsfile Corp. - September 29, 2026) - Appili Therapeutics Inc. (TSX: APLI) (OTC Pink: APLIF) (the "Company" or "Appili"), a biopharmaceutical company focused on drug development...
► Artikel lesen
04.09.Appili Therapeutics Inc: Appili Therapeutics TSX delisting review extended1
14.08.Appili Therapeutics Inc.: Appili Therapeutics Reports Financial and Operational Results for First Quarter of Fiscal Year 2027999Halifax, Nova Scotia--(Newsfile Corp. - August 14, 2026) - Appili Therapeutics Inc. (TSX: APLI) (OTC Pink: APLIF) (the "Company" or "Appili"), a biopharmaceutical company focused on drug development...
► Artikel lesen
10.07.Appili Therapeutics Inc: Appili Therapeutics delisting review extended2
04.07.Appili Therapeutics Inc: Appili receives NIAID contract termination notice2
04.07.Appili Therapeutics Inc.: Appili Therapeutics Announces Receipt from NIAID of a Notice of Termination for Convenience on the Contract for the VXV-01 Program588HALIFAX, Nova Scotia, July 03, 2026 (GLOBE NEWSWIRE) -- Appili Therapeutics Inc. (TSX: APLI; OTCPink: APLIF) (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for...
► Artikel lesen
27.06.Appili Therapeutics Inc.: Appili Therapeutics Reports Fiscal Year 2026 Financial and Operational Results887LIKMEZ® (ATI-1501) commercial momentum building in U.S. marketUS$40 million NIAID award supporting VXV-01 advancement through Phase 1 HALIFAX, Nova Scotia, June 26, 2026 (GLOBE NEWSWIRE) -- Appili...
► Artikel lesen
13.02.Appili Therapeutics Inc.: Appili Therapeutics Reports Financial and Operational Results for Third Quarter of Fiscal Year 2026261US$82 Million in Pending Proposals Across Multiple Infectious Disease Programs US$40 Million NIAID Funding Award Supports VXV-01 Development Through Phase 1 LIKMEZ® (ATI-1501) Commercial Momentum...
► Artikel lesen
13 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1